US patent granted to Theracell for demineralised bone fibre technology


logo-theracellAllosource logo

The United States Patent and Trademark Office (USPTO) is to issue TheraCell a patent for its demineralised bone fibre (DBF) technology.

TheraCell’s DBF technology is incorporated into two new demineralised cortical fiber allografts, AlloFuse cortical fibres and AlloFuse fibre boats, provided by AlloSource. AlloFuse cortical fibres and AlloFuse fibre boats can be used in a variety of spinal and orthopaedic procedures.

Both products consist of 100% demineralised cortical bone and, according to a company release, provide exceptional handling characteristics for bone fusion procedures.